Literature DB >> 31085628

High-saturated-fat diet-induced obesity causes hepatic interleukin-6 resistance via endoplasmic reticulum stress.

Logan K Townsend1, Kyle D Medak1, Willem T Peppler1, Grace M Meers2,3, R Scott Rector4,2,3, Paul J LeBlanc5, David C Wright6.   

Abstract

The relationship between liver interleukin-6 (IL-6) resistance following high-fat diet (HFD)-induced obesity and glucose intolerance is unclear. The purpose of this study was to assess the temporal development of hepatic IL-6 resistance and the role of endoplasmic reticulum (ER) stress in this process. We hypothesized that HFD would rapidly induce hepatic IL-6 resistance through a mechanism involving ER stress. Male C57BL/6N mice consumed chow or a HFD (60%) derived from lard (saturated) or olive oil (monounsaturated) for 4 days or 7 weeks before being injected intraperitoneally with IL-6 (6 ng·kg-1). Glucose, insulin, and pyruvate tolerance tests were used as proxies for systemic glucose metabolism and hepatic glucose production, respectively. Primary mouse hepatocytes were incubated with palmitate (saturated) and oleate (unsaturated) overnight, then treated with 20 ng/ml IL-6. ER stress was induced via tunicamycin or prevented by sodium phenylbutyrate (PBA). Seven weeks of a saturated, but not monounsaturated, HFD reduced hepatic IL-6 signaling in conjunction with hepatic ER stress. Palmitate directly impaired IL-6 signaling in hepatocytes along with inducing ER stress. Pharmacologically induced ER stress caused hepatic IL-6 resistance, whereas PBA reversed HFD-induced IL-6 resistance. Chronic HFD-induced obesity is associated with hepatic IL-6 resistance due to saturated FA-induced ER stress.
Copyright © 2019 Townsend et al.

Entities:  

Keywords:  fatty acids; glucose; hepatic glucose output; liver; steatohepatitis

Mesh:

Substances:

Year:  2019        PMID: 31085628      PMCID: PMC6602138          DOI: 10.1194/jlr.M092510

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  62 in total

1.  Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.

Authors:  J P Bastard; C Jardel; E Bruckert; P Blondy; J Capeau; M Laville; H Vidal; B Hainque
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

2.  Triglyceride accumulation protects against fatty acid-induced lipotoxicity.

Authors:  Laura L Listenberger; Xianlin Han; Sarah E Lewis; Sylvaine Cases; Robert V Farese; Daniel S Ory; Jean E Schaffer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

3.  Interleukin-6-deficient mice develop mature-onset obesity.

Authors:  Ville Wallenius; Kristina Wallenius; Bo Ahrén; Mats Rudling; Hans Carlsten; Suzanne L Dickson; Claes Ohlsson; John-Olov Jansson
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

Review 4.  Lipotoxic diseases.

Authors:  Roger H Unger
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

5.  Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes.

Authors:  J C Pickup; G D Chusney; S M Thomas; D Burt
Journal:  Life Sci       Date:  2000-06-08       Impact factor: 5.037

6.  Interleukin-6 induces cellular insulin resistance in hepatocytes.

Authors:  Joseph J Senn; Peter J Klover; Irena A Nowak; Robert A Mooney
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

7.  Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance.

Authors:  P A Kern; S Ranganathan; C Li; L Wood; G Ranganathan
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-05       Impact factor: 4.310

Review 8.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation.

Authors:  Peter C Heinrich; Iris Behrmann; Serge Haan; Heike M Hermanns; Gerhard Müller-Newen; Fred Schaper
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

9.  Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo.

Authors:  Hiroshi Inoue; Wataru Ogawa; Michitaka Ozaki; Sanae Haga; Michihiro Matsumoto; Kensuke Furukawa; Naoko Hashimoto; Yoshiaki Kido; Toshiyuki Mori; Hiroshi Sakaue; Kiyoshi Teshigawara; Shiyu Jin; Haruhisa Iguchi; Ryuji Hiramatsu; Derek LeRoith; Kiyoshi Takeda; Shizuo Akira; Masato Kasuga
Journal:  Nat Med       Date:  2004-01-11       Impact factor: 53.440

10.  Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.

Authors:  Joseph J Senn; Peter J Klover; Irena A Nowak; Teresa A Zimmers; Leonidas G Koniaris; Richard W Furlanetto; Robert A Mooney
Journal:  J Biol Chem       Date:  2003-01-30       Impact factor: 5.157

View more
  8 in total

1.  Reactive oxygen species-dependent regulation of pyruvate dehydrogenase kinase-4 in white adipose tissue.

Authors:  Logan K Townsend; Alyssa J Weber; Pierre-Andre Barbeau; Graham P Holloway; David C Wright
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-13       Impact factor: 4.249

2.  High-Fat Diet Aggravates the Intestinal Barrier Injury via TLR4-RIP3 Pathway in a Rat Model of Severe Acute Pancreatitis.

Authors:  Ying-Ru Su; Yu-Pu Hong; Fang-Chao Mei; Chen-Yang Wang; Man Li; Yu Zhou; Kai-Liang Zhao; Jia Yu; Wei-Xing Wang
Journal:  Mediators Inflamm       Date:  2019-12-17       Impact factor: 4.711

3.  Interleukin-6 actions in the hypothalamus protects against obesity and is involved in the regulation of neurogenesis.

Authors:  Vanessa C Bobbo; Daiane F Engel; Carlos Poblete Jara; Natalia F Mendes; Roberta Haddad-Tovolli; Thais P Prado; Davi Sidarta-Oliveira; Joseane Morari; Licio A Velloso; Eliana P Araujo
Journal:  J Neuroinflammation       Date:  2021-08-31       Impact factor: 8.322

4.  Diet-induced weight loss in obese/diabetic mice normalizes glucose metabolism and promotes functional recovery after stroke.

Authors:  Dimitra Karampatsi; Alexander Zabala; Ulrika Wilhelmsson; Doortje Dekens; Ellen Vercalsteren; Martin Larsson; Thomas Nyström; Milos Pekny; Cesare Patrone; Vladimer Darsalia
Journal:  Cardiovasc Diabetol       Date:  2021-12-22       Impact factor: 9.951

5.  The glucose lowering effects of CL 316,243 dissipate with repeated use and are rescued bycilostamide.

Authors:  Kyle D Medak; Greg L McKie; Hesham Shamshoum; Ian Seguin; David C Wright
Journal:  Physiol Rep       Date:  2022-02

6.  HIIT and MICT attenuate high-fat diet-induced hepatic lipid accumulation and ER stress via the PERK-ATF4-CHOP signaling pathway.

Authors:  Zhang Yuan; Liu Xiao-Wei; Wei Juan; Liu Xiu-Juan; Zhang Nian-Yun; Sheng Lei
Journal:  J Physiol Biochem       Date:  2022-03-22       Impact factor: 5.080

7.  Early triggers of moderately high-fat diet-induced kidney damage.

Authors:  Andrea Sánchez-Navarro; Miguel Ángel Martínez-Rojas; Rebecca I Caldiño-Bohn; Rosalba Pérez-Villalva; Elena Zambrano; Diana C Castro-Rodríguez; Norma A Bobadilla
Journal:  Physiol Rep       Date:  2021-07

8.  Role of HO-1 against Saturated Fatty Acid-Induced Oxidative Stress in Hepatocytes.

Authors:  Noriyoshi Ogino; Koichiro Miyagawa; Kenjiro Nagaoka; Yuki Matsuura-Harada; Shihona Ogino; Masashi Kusanaga; Shinji Oe; Yuichi Honma; Masaru Harada; Masamitsu Eitoku; Narufumi Suganuma; Keiki Ogino
Journal:  Nutrients       Date:  2021-03-19       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.